Frontotemporal dementia and/or amyotrophic lateral sclerosis 3

MONDO:0014640

An amyotrophic lateral sclerosis that has material basis in mutation in the SQSTM1 gene on chromosome 5q35.

Also known as: FTDALS3, frontotemporal dementia and/or amyotrophic lateral sclerosis 3, frontotemporal dementia and/or amyotrophic lateral sclerosis type 3

30 clinical trials for this condition and its sub-types, 0 tagged with Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Behavioral variant of frontotemporal dementia (42) ↑ Familial amyotrophic lateral sclerosis (29) ↑ Frontotemporal dementia with motor neuron disease (19) ↑ Frontotemporal dementia and/or amyotrophic lateral sclerosis (5) ↑ SQSTM1-related multisystem proteinopathy (0)

Including sub-types (30) Tagged with Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (0)

Trials to join now! 19 Not yet recruiting 2 Not yet finished but already full! 5 Completed 3 Terminated 1

Can a synthetic cannabinoid calm agitation in frontotemporal dementia?

Symptom relief Stopped early

This phase 2 trial tests whether nabilone, a synthetic cannabinoid, can reduce agitation in people with frontotemporal dementia (FTD). Participants receive both nabilone and a placebo in random order to compare effects. The study includes adults with behavioral variant FTD or pri…

Phase 2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief

Last updated Jul 30, 2026 00:00 UTC

Frontotemporal dementia and/or amyotrophic lateral sclerosis 3

Where it sits in the disease tree

Can a synthetic cannabinoid calm agitation in frontotemporal dementia?